MANHARD KIMBERLY 4
4 · HERON THERAPEUTICS, INC. /DE/ · Filed Apr 17, 2023
Insider Transaction Report
Form 4
MANHARD KIMBERLY
Director
Transactions
- Exercise/Conversion
Common Stock
2023-04-13+4,564→ 29,747 total - Tax Payment
Common Stock
2023-04-13$2.88/sh−1,417$4,081→ 28,330 total - Exercise/Conversion
Common Stock
2023-04-13+1,250→ 25,183 total - Exercise/Conversion
Restricted Stock Units
2023-04-13−1,250→ 7,500 total→ Common Stock (1,250 underlying) - Exercise/Conversion
Restricted Stock Units
2023-04-13−4,564→ 27,936 total→ Common Stock (4,564 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
- [F3]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).
- [F4]The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).